Terms: = Colorectal cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Diagnosis
6 results:
1. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract] [Full Text] [Related]
2. 'I Can't Keep Up!': an update on advances in soft tissue pathology occurring after the publication of the 2020 World Health Organization classification of soft tissue and bone tumours.
Folpe AL
Histopathology; 2022 Jan; 80(1):54-75. PubMed ID: 34958510
[TBL] [Abstract] [Full Text] [Related]
3. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract] [Full Text] [Related]
4. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Park BJ; Cha MK; Kim IH
BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
[TBL] [Abstract] [Full Text] [Related]
5. Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis.
Lin YM; Ono K; Satoh S; Ishiguro H; Fujita M; Miwa N; Tanaka T; Tsunoda T; Yang KC; Nakamura Y; Furukawa Y
Cancer Res; 2001 Sep; 61(17):6345-9. PubMed ID: 11522623
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics of metachronous colorectal tumors.
Rennert G; Robinson E; Rennert HS; Neugut AI
Int J Cancer; 1995 Mar; 60(6):743-7. PubMed ID: 7896438
[TBL] [Abstract] [Full Text] [Related]
